Prognostic value of neutrophil-to-lymphocyte ratio in mCRPC patients treated with abiraterone, enzalutamide and docetaxel: a retrospective single-center study. Arch Ital Urol Androl. Published online August 7, 2026. doi:10.4081/aiua.2026.15630